ENOV (Enovis) Total Liabilities: $2,353 Mil (As of Mar. 2026)


ENOV Enovis Corp ENOV
60 GF Score
Price $22.02
GF Value $49.60
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Enovis Total Liabilities?

Enovis ENOV -3.04% 60 Total Liabilities is $2,353 Mil as of Mar. 2026. GuruFocus rates ENOV with a GF Score™ of 60/100 and a GF Value™ of $49.60 (Possible Value Trap). The stock has 6 warning signs investors should review.

Enovis's Total Liabilities for the quarter that ended in Mar. 2026 was $2,353 Mil.

Enovis's quarterly Total Liabilities declined from Sep. 2025 ($2,409.69 Mil) to Dec. 2025 ($2,342.84 Mil) but then increased from Dec. 2025 ($2,342.84 Mil) to Mar. 2026 ($2,352.76 Mil).

Enovis's annual Total Liabilities increased from Dec. 2023 ($1,088.63 Mil) to Dec. 2024 ($2,154.45 Mil) and increased from Dec. 2024 ($2,154.45 Mil) to Dec. 2025 ($2,342.84 Mil).

Enovis Total Liabilities Historical Data

* Premium members only.

The historical data trend for Enovis's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enovis Total Liabilities Chart

Enovis Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3,854.48 823.45 1,088.63 2,154.45 2,342.84

Enovis Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,254.82 2,440.44 2,409.69 2,342.84 2,352.76
ENOV
60GF Score
Enovis Corp ENOV
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Enovis Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Enovis's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=598.474+(1319.793+424.568
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=2,343

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=3834.737-1491.902
=2,343

Enovis's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=608.665+(1350.294+393.805
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=2,353

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=3832.256-1479.492
=2,353

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of $2,353 Mil mean?
Enovis (ENOV) has a Total Liabilities of $2,353 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Enovis and its competitors.
Is Enovis' Total Liabilities too high?
Enovis' current Total Liabilities is $2,353 Mil. Overall, Enovis has a GF Score™ of 60/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Enovis' Total Liabilities compare to INSP and PRCT?
Enovis' Total Liabilities of $2,353 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Medical Devices & Instruments company?
A good Total Liabilities depends on the Medical Devices & Instruments industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Enovis and its competitors. Enovis's current Total Liabilities is $2,353 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Enovis stock overvalued right now?
Based on GuruFocus' analysis, Enovis (ENOV) is currently considered Possible Value Trap. The stock's GF Value™ is $49.60, compared to a current price of $22.02 — trading 55.6% below its estimated fair value. The current Total Liabilities is $2,353 Mil. Enovis' overall GF Score™ is 60/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Enovis (ENOV), the current Total Liabilities is $2,353 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Enovis (ENOV) Overvalued in 2026?

Based on GuruFocus' analysis, Enovis stock appears to be undervalued. The current stock price of $22.02 is trading 55.6% below its estimated GF Value™ of $49.60. GuruFocus considers Enovis to be Possible Value Trap.

Key valuation signals for ENOV:

  • Total Liabilities: $2,353 Mil
  • GF Value™: $49.60 vs. price of $22.02 (55.6% below fair value)
  • GF Score™: 60/100 with 6 warning signs

No single metric tells the full story. See the ENOV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Enovis Business Description

Address 2711 Centerville Road, Suite 400, Wilmington, DE, USA, 19808
Enovis Corp is a medical technology manufacturer and distributor of medical devices used in reconstructive surgery, rehabilitation, pain management, and physical therapy. Its products support patient care from injury prevention through post-surgical or post-injury rehabilitation and treatment of degenerative conditions. The company's reportable segments include Prevention & Recovery and Reconstructive segments. The majority of revenueis derived from the Prevention & Recovery segment, which includes products that are used by orthopedic specialists, primary care physicians, physical therapists, chiropractors, athletic trainers and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformitiesand sports-related injuries.
60GF Score

Get the complete analysis for ENOV

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$22.02
Price
$49.60
GF Value